RECRUITING
I'm interested ...!!
Know and Own Your Movement-related Metrics Via Wearable Devices
This study aims to promote daily physical activity in cancer survivors who are at high risk for type 2 diabetes (T2D) by using a personalized biological-based feedback strategy. T2D is one of the most common co-occurring conditions in cancer survivors and can worsen cancer-related health outcomes, especially in those who are insufficiently active. The investigators hypothesize that seeing the immediate impacts of exercise on their biological status will motivate cancer survivors to exercise. The investigators will use real-time data from continuous glucose monitor to demonstrate the acute impact of physical activity and measure daily activity levels using wearable trackers. As wearable sensor technology is constantly advancing, this study is the first step to exploring how researchers can use wearable sensors to help people make a direct connection between their daily behaviors and health outcomes.
Conditions:
🦠 Cancer 🦠 Survivorship
🗓️ Study Start (Actual) 29 March 2023
🗓️ Primary Completion (Estimated) 1 December 2024
✅ Study Completion (Estimated) 1 December 2024
👥 Enrollment (Estimated) 50
🔬 Study Type INTERVENTIONAL
📊 Phase NA
Locations:
📍 Arlington, Texas, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • * be 18 years or older
    • * have had a diagnosis of cancer
    • * have completed curative-intended treatment for at least 3 months (except hormone therapy or long-term maintenance chemotherapy)
    • * be at high-risk for type 2 diabetes based on the American Diabetes Association Type 2 Diabetes Risk Test
    • * currently insufficiently active
    • * capable of participating in moderate-vigorous intensity unsupervised exercise
    • * have no current diagnosis or history of type 1 or 2 diabetes
    • * able to speak, read, and write in English
    • * have a smartphone with daily internet access

    Exclusion Criteria:

    • * currently taking oral antidiabetic agents (OADs)
    • * current treatment with any insulin regimen other than basal insulin, e.g. prandial or pre-mixed insulin
    • * currently pregnant
    • * on dialysis
    • * have self-reported health issues that limit physical activity
    • * work overnight shifts
    • * unwilling to use the study devices
    • * current participation in other exercise or weight loss-related program or intervention
    • * currently on a low-carb diet
    • * current use of other implanted medical devices such as pacemakers
    • * do not have a smartphone that is compatible with the Fitbit and the LibreLink apps
Ages Eligible for Study: 18 Years to N/A (ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 1 August 2022
  • First Submitted that Met QC Criteria 3 August 2022
  • First Posted 5 August 2022

Study Record Updates

  • Last Update Submitted that Met QC Criteria 31 May 2024
  • Last Update Posted 3 June 2024
  • Last Verified May 2024
I'm interested ...!!